Clinical Trial Update: Study Evaluating A Planned Transition From Tacrolimus To Sirolimus In Kidney Transplant Recipients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update examining a planned switch from tacrolimus to sirolimus in kidney transplant recipients; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Allograft Rejection

Drugs mentioned

• Prograf (Tacrolimus)
• Rapamune (sirolimus)

Snippet

Sponsor: Pfizer | Conditions: Graft Rejection, Kidney Transplant | Phase 4 | Status: COMPLETED | Results posted: 2014-09-18